Clincosm LogoSign in Get a demo

clear cell renal cell carcinoma

Showing 26 - 50 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Solid Tumors Trial (AB521)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • Solid Tumors
  • (no location specified)
Sep 7, 2022

Melanoma Stage IV, Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Oslo (Fecal Microbiota

Recruiting
  • Melanoma Stage IV
  • +4 more
  • Fecal Microbiota Transplant (FMT)
  • Oslo, Norway
    Oslo University Hospital
Aug 29, 2022

Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Duarte, California
  • +22 more
Aug 17, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

From Clear Cell Renal Cell Carcinoma

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Urinary sample
  • Saint-Étienne, France
    Chu Saint-Etienne
Jul 13, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (procedure,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Cryosurgery
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 6, 2022

Clear Cell Renal Cell Carcinoma Trial in Duarte, Nashville (XmAb819)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • XmAb819
  • Duarte, California
  • +1 more
Jun 20, 2022

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-P16-093, 18F-FDG)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 21, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in United

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Ascorbic Acid
  • Pazopanib Hydrochloride
  • Peoria, Illinois
  • +4 more
Mar 18, 2022

Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • No intervention was required for patients or control group in this study
  • Jinan, China
    The First Affiliated Hospital of Shandong First Medical Universi
Mar 7, 2022

Clear Cell Renal Cell Carcinoma, First-line Treatment Trial in Shanghai (AK104, axitinib)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • First-line Treatment
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

Advanced Kidney Cancer, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in United States (Guadecitabine, Durvalumab)

Active, not recruiting
  • Advanced Kidney Cancer
  • +2 more
  • Chicago, Illinois
  • +4 more
Feb 16, 2022

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 16, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Birmingham, Alabama
  • +986 more
Jan 13, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Rochester, Minnesota
  • +1 more
Jan 12, 2022

Clear Cell Renal Cell Carcinoma Trial in Korea, Republic of, United States (X4P-001, axitinib)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +19 more
Sep 20, 2021

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer Trial in New Brunswick (drug, other, procedure)

Terminated
  • Clear Cell Renal Cell Carcinoma
  • Stage I Renal Cell Cancer
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 14, 2021

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Dallas ([18F]PT2385, Positron Emission Tomography/Computed

Recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 23, 2021

Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)

Completed
  • Carcinoma, Renal Cell
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Yokohama City, Kanagawa, Japan
    Yokohama City University Hospital
Aug 18, 2021

Clear Cell Renal Cell Carcinoma Trial in United States (Placebo, CB-839, everolimus)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +37 more
Aug 16, 2021